Dr. Roy Beveridge joined Humana in 2013 as Senior Vice President and Chief Medical Officer. He is responsible for developing and implementing Humana’s clinical strategy, with an emphasis on advancing the company’s integrated care delivery model.
Dr. Beveridge is known for creating collaborative environments among physician communities and providing thought leadership around population health. He is a member of Humana’s Management Team, which sets the strategic direction for the company.
Previously, Dr. Beveridge served as Chief Medical Officer for McKesson Specialty Health, a Dallas-based subsidiary of McKesson Inc. Prior to McKesson’s acquisition of US Oncology in 2010, he served as the Executive Vice President and Medical Director at US Oncology. Dr. Beveridge also was the Co-Director of the Bone Marrow Transplant Program at INOVA Fairfax Hospital in Falls Church, Virginia. He has published extensively in the fields of medical oncology, quality design and population health.
Dr. Beveridge earned a Bachelor of Arts degree from Johns Hopkins University and a medical degree from Cornell University Medical College. He completed his residency in internal medicine at University of Chicago Hospitals and his fellowship at Johns Hopkins Hospital.
Board certified in medical oncology and internal medicine, Dr. Beveridge has authored numerous articles on a wide range of medical topics such as hematology, stem cell transplantation and quality/value-based medical practice.
Dr. Beveridge is a member of the American Medical Association, American Society of Clinical Oncology (ASCO) and the American Society of Hematology.
Successful population health management requires a broad approach to care that includes helping patients manage social factors outside the clinician’s office: from air quality and sedentary lifestyles to food insecurity, transportation, and even social isolation.
This is the core lesson Humana learned from its Bold Goal initiative, a program designed to help communities it serves become 20 percent healthier by 2020. The company is collaborating with seven communities across Louisiana, Florida, Tennessee, Texas and Kentucky to make healthcare easier and thus create more “Healthy Days,” as measured by the CDC’s survey tool for benchmarking community health.
In this session, attendees will hear how through its Bold Goal program Humana discovered that to improve community health requires local partnerships, clinical interventions and engagement strategies to increase resources for patients that lead to behavior change.
- How to develop a holistic population health care strategy that incorporates social factors into the health and clinical services.
- How to identify key challenges and opportunities within each population and recommend ways to address them.
- The importance of incorporating the right technology to facilitate better care and quicker access.